Literature DB >> 7983125

Supramalleolar tibial osteotomy for haemophilic arthropathy of the ankle.

M S Pearce1, M A Smith, G F Savidge.   

Abstract

We report the results of supramalleolar varus osteotomy on seven ankles (in six patients) for haemophilic arthropathy and secondary valgus deformity. The operation reduced pain and the frequency of intra-articular bleeding while preserving joint function for a mean of nine years. The procedure is an attractive alternative to the more commonly used surgical option of arthrodesis.

Entities:  

Mesh:

Year:  1994        PMID: 7983125

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  7 in total

1.  Single-stage supramalleolar osteotomy for coronal plane deformity.

Authors:  Alexej Barg; Charles L Saltzman
Journal:  Curr Rev Musculoskelet Med       Date:  2014-12

2.  [Osteotomies of the distal tibia and hindfoot for ankle realignment].

Authors:  B Hintermann; M Knupp; A Barg
Journal:  Orthopade       Date:  2008-03       Impact factor: 1.087

3.  Outcome of osteotomies for the treatment of haemophilic arthropathy of the knee.

Authors:  K Trieb; J Panotopoulos; H Hartl; W Brodner; I Pabinger; A Wanivenhaus
Journal:  Langenbecks Arch Surg       Date:  2003-11-14       Impact factor: 3.445

4.  Multiplanar supramalleolar osteotomy in the management of complex rigid foot deformities in children.

Authors:  Kyle Nelman; Dennis S Weiner; Melanie A Morscher; Kerwyn C Jones
Journal:  J Child Orthop       Date:  2009-01-08       Impact factor: 1.548

5.  Prevention of the musculoskeletal complications of hemophilia.

Authors:  E C Rodriguez-Merchan
Journal:  Adv Prev Med       Date:  2012-06-14

6.  Physiotherapy treatment in patients with hemophilia and chronic ankle arthropathy: a systematic review.

Authors:  Rubén Cuesta-Barriuso; Antonia Gómez-Conesa; José Antonio López-Pina
Journal:  Rehabil Res Pract       Date:  2013-08-12

Review 7.  Knee and Ankle Arthroplasty in Hemophilia.

Authors:  Luigi Piero Solimeno; Gianluigi Pasta
Journal:  J Clin Med       Date:  2017-11-22       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.